Next Issue
Volume 74, July
Previous Issue
Volume 74, March
 
 
arm-logo

Journal Browser

Journal Browser
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.

Adv. Respir. Med., Volume 74, Issue 2 (June 2006) – 20 articles , Pages 139-241

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
75 KiB  
Review
Using Flow Cytometry in Laboratory Diagnosis of Allergic Diseases
by Wojciech Mędrala, Anna Wolańczyk-Mędrala and Grzegorz Gogolewski
Adv. Respir. Med. 2006, 74(2), 239-241; https://doi.org/10.5603/ARM.28060 - 10 Jun 2006
Viewed by 258
Abstract
Bazofile i mastocyty Sil komorkami efektorowymi reakcji zaleznej od IgE, nazywana takze reakcja typu I wg [...] Full article
75 KiB  
Review
The Importance of Eosinophil Cationic Protein in Pathogenesis of Allergic Diseases
by Grzegorz Gogolewski, Anna Wolańczyk-Mędrala and Wojciech Mędrala
Adv. Respir. Med. 2006, 74(2), 236-238; https://doi.org/10.5603/ARM.28059 - 10 Jun 2006
Viewed by 243
Abstract
Wyniki badan ostatnich kilkunastu lat dostarcza­jll wielu danych na temat istotnej roli eozynofila w patogenezie licznych chorob o podlozu zapalnym [...] Full article
82 KiB  
Review
The Induced Sputum—Methodology and Clinical Usefulness
by Maria Porzezińska and Jan Marek Słomiński
Adv. Respir. Med. 2006, 74(2), 232-235; https://doi.org/10.5603/ARM.28058 - 10 Jun 2006
Viewed by 226
Abstract
Plwocina jest wydzielincl blony sluzowej drog od­dechowych [...] Full article
119 KiB  
Review
Bacteria of the Genus Acinetobacter: Clinical Significance And Therapy of Infections
by Marta Wróblewska
Adv. Respir. Med. 2006, 74(2), 227-231; https://doi.org/10.5603/ARM.28057 - 10 Jun 2006
Viewed by 249
Abstract
Bakterie z rodzaju Acinetobacter naleza do grupy Gram-ujemnych paleczek niefermentujacych, do ktorych zalicza sie rowniez patogeny takie jak Pseu­domonas aeruginosa, Stenotrophomonas maltophi­lia i Burkholderia cepacia [...] Full article
93 KiB  
Case Report
Pulmonary Complications in Patient with Ulcerative Colitis, Treated with 5-Aminosalicylic Preparations
by Piotr Radwan, Tomasz Łupina, Karolina Radwan-Kwiatek and Janusz Milanowski
Adv. Respir. Med. 2006, 74(2), 224-226; https://doi.org/10.5603/ARM.28056 - 10 Jun 2006
Viewed by 259
Abstract
Pulmonary complications in patients with ulcerative colitis treated with 5-aminosalicylic acid are infrequent adverse events. The authors present a 35-year-old man, talcing sulfasalazine and mesalazine in whom pulmonary abnormalities resembling tuberculosis were observed during several months of therapy. Withdrawal of mesalazine resulted in [...] Read more.
Pulmonary complications in patients with ulcerative colitis treated with 5-aminosalicylic acid are infrequent adverse events. The authors present a 35-year-old man, talcing sulfasalazine and mesalazine in whom pulmonary abnormalities resembling tuberculosis were observed during several months of therapy. Withdrawal of mesalazine resulted in complete resolution of lung injury. Patient is doing well on maintenance treatment with im­munosuppressants. Full article
71 KiB  
Case Report
Latent Tetany Masked by Syndroms of Bronchial Asthma and Depressive Syndrome. Case Raport
by Beata Wajda, Adrianna Drozdowska, Krzysztof Kuziemski, Lucyna Górska, Katarzyna Lewandowska and Ewa Jassem
Adv. Respir. Med. 2006, 74(2), 221-223; https://doi.org/10.5603/ARM.28055 - 10 Jun 2006
Viewed by 366
Abstract
Tetany, which occurs in young women, poses common diagnostic problem. Two types of tetany are distinguished: one which is characterized by hypocalcemia and which rarely occurs (in person after strumectomy in the course of post-operational hypoparathyroidism) and latent one, which occurs more often. [...] Read more.
Tetany, which occurs in young women, poses common diagnostic problem. Two types of tetany are distinguished: one which is characterized by hypocalcemia and which rarely occurs (in person after strumectomy in the course of post-operational hypoparathyroidism) and latent one, which occurs more often. In the literature there is a lack of precise data concerned witch most probably results from its underestimation. Clinical symptoms which appear in latent tetany (normocalcemic) are related to the intracellular magnesium ddiciency and increased respiratory drive. A noncharacteristic clinical picture and the lack of a pathognomonic symptom, cause that despite of the fearly common occurrence, the latent tetany is rarely recognized. In this paper the case of a 53 year old women has been described. The women had the symptoms of gastroesopha­geal reflux of asthma and depressive syndrome, witch masked the symptoms of the latent tetany. Full article
99 KiB  
Case Report
Thrombocytopenia Probably Heparin-Induced in Women with Tumor of the Heart and Pulmonary Embolism
by Renata Gralec, Małgorzata Dybowska, Paweł Kuca, Janusz Burakowski and Witold Tomkowski
Adv. Respir. Med. 2006, 74(2), 216-220; https://doi.org/10.5603/ARM.28054 - 10 Jun 2006
Viewed by 324
Abstract
43 years old women with tumor of the right ventricle was admitted to ICU due to pulmonary embolism and suspicion for heparin-induced thrombocytopenia. Thrombocytopenia was successfully treated with Arixtra and the patient was qualified for the cardio surgery intervention. Heparin is widely used [...] Read more.
43 years old women with tumor of the right ventricle was admitted to ICU due to pulmonary embolism and suspicion for heparin-induced thrombocytopenia. Thrombocytopenia was successfully treated with Arixtra and the patient was qualified for the cardio surgery intervention. Heparin is widely used in treatment and prophylaxis of venous thromboembolism and other diseases. One of the most important adverse effect of treatment with heparin is heparin-inducted thrombocytopenia (HIT), which is one of the most frequent drug-induced, immune-mediated type ofthrombocytopenia. Ifit is unrecognized is associated with significant morbidity and mortality. According to our knowledge this is first report of Arixtra usage in patient with suspicion of HIT in Poland. Full article
506 KiB  
Case Report
Chylothorax in Patients with Diffuse Pulmonary Lymphangiomatosis
by Elżbieta Wiatr, Renata Langfort, Tadeusz Orłowski, Jacek Grudny, Dariusz Gawryluk, Włodzimierz Kupis, Jerzy Usiekniewicz, Karina Oniszh, Barbara Burakowska and Kazimierz Roszkowski
Adv. Respir. Med. 2006, 74(2), 209-215; https://doi.org/10.5603/ARM.28053 - 10 Jun 2006
Viewed by 269
Abstract
The occurence of chylothorax is uncommon and usually is caused by trauma or neoplastic process of the mediastinum. Primary lymphatic lesions of the lungs are extremly rare. One of them is lymphangiomatosis—diffuse lesions characterized primarily by an increased number of complex anastomosing lymphatic [...] Read more.
The occurence of chylothorax is uncommon and usually is caused by trauma or neoplastic process of the mediastinum. Primary lymphatic lesions of the lungs are extremly rare. One of them is lymphangiomatosis—diffuse lesions characterized primarily by an increased number of complex anastomosing lymphatic channels in which dilatation is secondary phenomenon. These lesions can involve lungs, mediastinum and pleura. The prog­nosis for the patients with this disease limited to the thorax is guarded and progressive although some patients have realtively indolent course. We present 2 patients : 18-years old boy and 17-years old girl. admitted to hospital because of chylothorax. The diagnostic did could not allow to discover disruption of thoracic duct, even during thoracoscopy. In material taken from the pleura and mediastinum during exploratory thoracotomy—diffuse pul­monary lymphangiomatosis was found. CT examination of the chest revealed osteolysis of the spine. The girl died after 6 weeks from the first symptoms and boy is observed for 18 months with symptoms of progressive restrictive lung disease. Full article
130 KiB  
Article
Humoral Immune Response against Mycobacterial Antigens in Patients with Tuberculosis and Mycobacterial Infections Other than Tuberculosis
by Urszula Demkow, Beata Białas-Chromiec, Małgorzata Filewska, Tadeusz Zielonka, Dorota Michałowska-Mitczuk, Jan Kuś, Beata Broniarek-Samson, Ewa Augustynowicz-Kopeć, Zofia Zwolska and Ewa Rowińska-Zakrzewska
Adv. Respir. Med. 2006, 74(2), 203-208; https://doi.org/10.5603/ARM.28052 - 10 Jun 2006
Viewed by 270
Abstract
The aim of the study was to compare humoral immune response against various mycobacterial anti­gens in TB and MOTT vs. healthy control group. 350 serum samples from TB patients, 20 samples from MOTT pa­tients and 58 samples from healthy donors were examined. ELISA [...] Read more.
The aim of the study was to compare humoral immune response against various mycobacterial anti­gens in TB and MOTT vs. healthy control group. 350 serum samples from TB patients, 20 samples from MOTT pa­tients and 58 samples from healthy donors were examined. ELISA detecting IgG, lgA and IgM against antigens: 38 kDa and 16 kDa, 38 kDa and lipoarabinomannan, and A-60 were used. Mean IgG level was higher in TB compared to healthy controls (p < 0.001). Mean IgG level against 38kDa and 38 + 16 kDa mycobacterial antigens was higher in TB than in MOTT group. Mean level of the IgG, IgA and IgM antibodies against LAM was higher in MOTT compared to TB patients. In all subgroups person-to-person heterogeneity of antigen recognition was observed. Humoral immune response to recombinant mycobacterial antigens significantly differs in TB and MOTT patients. Full article
126 KiB  
Article
Invasive Aspergillosis (IA) In Patients Treated in the Institute of Tuberculosis and Chest Diseases in the Years 1993–2005—Diagnostic Problems
by Paweł Ramiszewski, Dariusz Gawryluk, Barbara Podsiadło, Elżbieta Wiatr, Janusz Szopiński, Ewa Rowińska-Zakrzewska, Iwona Bestry, Renata Langfort and Kazimierz Roszkowski-Śliż
Adv. Respir. Med. 2006, 74(2), 197-202; https://doi.org/10.5603/ARM.28051 - 10 Jun 2006
Viewed by 315
Abstract
The aim of this study was to present the diagnostic problems in pts treated for invasive aspergillosis (IA) in the Illrd Clinic of the Institute of Tuberculosis in the years 1993–2005. The material consisted of clinical documentation of 18 pts. 15 out of [...] Read more.
The aim of this study was to present the diagnostic problems in pts treated for invasive aspergillosis (IA) in the Illrd Clinic of the Institute of Tuberculosis in the years 1993–2005. The material consisted of clinical documentation of 18 pts. 15 out of 18 pts (83.4%) died. In all those cases autopsy examination was done. In 13 pts IA was the main and in another 2 only the accessory cause of death. AU pts were treated with corticosteroids and/or cytostatic drugs because of lung cancer (13 pts), haematologic disorders (1 pts), Wegener's granulomatosis (3 pts) and idiopathic pulmonary fibrosis (1 pts). In 13 out of 18 pts granulocytopenia was revealed (on an average from 0.008 × 109/L to 0.95 × 109/L) one month before death. In 13 pts IA was limited to the lungs, in 5 others there were also fungal lesions in brain, kidneys, liver, spleen, pleura, pericardium and heart. Pts with disseminated fonn ofIA had significantly lower granulocyte count and were treated with higher doses of corticosteroids than others. Immunosupressive drugs and granulocytopenia can be regarded as predisposing factors. IA was diagnosed before death only in 5 out of 18 pts. This was mainly caused by the lack of the symptoms of in­fection (4 pts) and negative results ofmycological (6 pts) and serological examination (8 pts). We should underline that mycological examination was only done in 11 pts and serological examination of blood for fungal antigen only in 6 pts. We conclude that mycological infection ought to be searched in all pts treated with high doses of corticosteroids and those with prolonged granulocytopenia, especially if they have the symptoms of infection which does not respond to antibiotic therapy. Full article
124 KiB  
Article
Increased Levels of RANTES in Induced Sputum of Chronic Asthma but Not in Seasonal Grass Pollen-Induced Rhinitis
by Adam Barczyk, Ewa Sozańska, Malgorzata Farnik, Iwona Stępniak-Ziółkiewicz, Joanna Nizio-Mąsior and Władysław Pierzchała
Adv. Respir. Med. 2006, 74(2), 191-196; https://doi.org/10.5603/ARM.28050 - 10 Jun 2006
Cited by 1 | Viewed by 332
Abstract
Backgroud: Allergic rhinitis is one of risk factors for development of allergic asthma. Meth­ods: 9 patients with asthma, 16 patients with seasonal allergic rhinitis (SAR) due to grass or rye pollen sensiti­zation and 17 healthy control subjects were recruited to the study. SAR [...] Read more.
Backgroud: Allergic rhinitis is one of risk factors for development of allergic asthma. Meth­ods: 9 patients with asthma, 16 patients with seasonal allergic rhinitis (SAR) due to grass or rye pollen sensiti­zation and 17 healthy control subjects were recruited to the study. SAR patients were identified by history, skin­prick test, specific lgE and positive nasal allergen challenge. Every subject underwent the methacholine bronchial provocation test and sputum induction. Levels of RANTES were measured in supernatant of induced sputum. Results: Increased percentage of eosinophils in induced sputum in asthma compared to control group (p = 0.01) but not in SAR patients compared to healthy subjects (p = 0.13) were found. Similarly, asthmatic patients (p = 0.01) but not SAR patients had increased levels of RANTES in sputum compared to healthy subjects. Conclusion: Increased levels of RANTES in induced sputum of patients with chronic asthma but not in SAR patients indicate that RANTES is important in pathogenesis of chronic airway inflammation. Full article
106 KiB  
Article
VEGF in the Cancer Anorexia-Cachexia Syndrome in Patients with Lung Cancer
by Bożena Weryńska, Monika Kosacka, Marcin Gołecki and Renata Jankowska
Adv. Respir. Med. 2006, 74(2), 186-190; https://doi.org/10.5603/ARM.28049 - 10 Jun 2006
Viewed by 298
Abstract
Cancer anorexia-cachexia syndrome( CACS) occurs in 30–80% of patients with cancer. CACS is con­nected with poor prognosis and higher risk of treatment complications. CACS belongs to the common cause of death in cancer patients. Main role in the development of this syndrome play [...] Read more.
Cancer anorexia-cachexia syndrome( CACS) occurs in 30–80% of patients with cancer. CACS is con­nected with poor prognosis and higher risk of treatment complications. CACS belongs to the common cause of death in cancer patients. Main role in the development of this syndrome play cytokines like TNF, interleukin 1 and 6 and interferon α and γ. The importance of a lot of other substances is still unknown. VEGF promotes new vessels development, enhance vascular permeability and plays a role in inflammatory reaction. The aim of this study was comparison of VEGF levels in patients with lung cancer with and without CACS and in control group. The serum levels of VEGF were measured by ELISA method. The VEGF was significatly higher in patients with lung cancer then in control group (p = 0.004). There were no correlations between VEGF and weight lost, histological type and stage of disease. This suggest that VEGF doesnt play a role in development of CACS. Full article
173 KiB  
Article
Epidemiological Situation Concerning Lung Cancer in Wielkopolska in 1975–2002
by Rodryg Ramlau, Joanna Didkowska, Urszula Wojciechowska, Wojciech Tarkowski and Wojciech Dyszkiewicz
Adv. Respir. Med. 2006, 74(2), 179-185; https://doi.org/10.5603/ARM.28048 - 10 Jun 2006
Viewed by 271
Abstract
Lung cancer is the main cause of cancer deaths around the world. At 12% of all cancer incidents, lung cancer is the most frequent single cause of death, of both males and females. In 2002 among male population in Po­land, lung cancer was [...] Read more.
Lung cancer is the main cause of cancer deaths around the world. At 12% of all cancer incidents, lung cancer is the most frequent single cause of death, of both males and females. In 2002 among male population in Po­land, lung cancer was the second, following heart failure, cause of death, ranging at 8% of deaths in general. It was third cause of death among females ranging at 2.3% in general. Considering cancer deaths in 2002 in Wielkopolska, lung cancer was most frequent cause of death among males (30%) and second frequent among females (10.4%). The last 25 years the number of deaths decreased among younger generation of males (first in the age group 20–44, later in the middle age group) and this phenomenon has dominated the general picture of cancer among males. However the increase of mortality rates in the older age group might be still observed. The constant increase of mortality has been observed among females, especially in the middle age group (45–64). It should be highlighted that the level of mortality has been equalled in both genders in the youngest age group (20–44), which means sud­denly growing risk among young population of women in Wielkopolska. Full article
204 KiB  
Article
Analysis of the Treatment (Neoadjuvant Chemotherapy and Surgery) in IIb and IIIa Stages of Non-small Cell Lung Cancer
by Beata Ptaszek, Mariusz Chabowski, Elżbieta Wiatr, Tadeusz M. Orłowski, Renata Langfort, Iwona Bestry and Kazimierz Roszkowski-Śliż
Adv. Respir. Med. 2006, 74(2), 171-178; https://doi.org/10.5603/ARM.28047 - 10 Jun 2006
Viewed by 337
Abstract
The aims: (1) comparison ofNSCLC stages according to bronchoscopic and radiological findings with pathological outcome (mediastinoscopy), (2) efficacy of the neoadjuvant ChT by means of nodal involvement and primary tumour (downstaging), (3) influence ofChT on the surgical procedures' extension and its morbidity Material [...] Read more.
The aims: (1) comparison ofNSCLC stages according to bronchoscopic and radiological findings with pathological outcome (mediastinoscopy), (2) efficacy of the neoadjuvant ChT by means of nodal involvement and primary tumour (downstaging), (3) influence ofChT on the surgical procedures' extension and its morbidity Material and methods: I 00 consecutive patients with resectable NSCLC in stages 11B (13 pts) or IIIA (57 pts), who were qualified to neoadjuvant ChT, participated in this study (77 men and 23 women, aged 42–73). Tumour and lymph nodes (mediastinal and hilar) were measured in CT scan. Mediastinoscopy was performed in 70 pts (70%). Majority of patients (87%) received two cycles ofneoadjuvant ChT (cisplatin 80 mg/m2 iv on day 1 and vinorelbine 25 mg/m2 on day 1 and 5) administered every 21 days. After ChT 85 patients were qualified to surgery. The results: The metastases in mediastinoscopy were excluded in 32 out of 45 patients (71%), whose lymph nodes were enlarged in CT scan (radiological false positive). Metastases were confirmed in 4 out of 25 patients (16%), whose lymph nodes were normal in CT scan (radiological false negative). After ChT the regression of the disease (PR+CR) was noted in 37% of patients. Pneumonectomy was performed in 23 (27%) pts, bilobectomy in 11 (13%) pts, lobectomy in 39 (46%) pts and “extended” (sleeve) lobectomy in 12 (14%) pts. Resected material was exam­ined microscopically very exactly in patients, in whom mediastinoscopy was performed before treatment. Down­staging was confirmed in 6 out of 15 patients (40%). Conclusions: Neoadjuvant ChT was effective in 37% of patients and allowed us to perform less exten­ sive surgery in these patients. 22 (64.7%) out of 34 patients who responded to ChT underwent lobecto­ my. Only 17 (36%) out of 51 patients who did not respond to ChT had lobectomy performed. Generally, 85 pts were operated with postroperative complications in 22.3% patients and 2.3% mortality rate. Full article
166 KiB  
Article
Significance of Virological Diagnostics for the Effective Treatment of Hosptalized Patients Infected with Influenza Virus
by Magdalena Machała, Elżbieta Wiatr, Dariusz Gawryluk and Lidia B. Brydak
Adv. Respir. Med. 2006, 74(2), 166-170; https://doi.org/10.5603/ARM.28046 - 10 Jun 2006
Cited by 1 | Viewed by 326
Abstract
In the case of influenza disease there is no possible to make unquestionable diagnosis only on the basis of clinical picture. Therefore, virological laboratory diagnostics is important, especially in hospitalized patients and those who highly risk post-influenza complications and severe course of the [...] Read more.
In the case of influenza disease there is no possible to make unquestionable diagnosis only on the basis of clinical picture. Therefore, virological laboratory diagnostics is important, especially in hospitalized patients and those who highly risk post-influenza complications and severe course of the disease. Virological diagnostic tests for influenza and positive result obtained in these tests allow to use effective antiviral-antiinfluenza drugs as new generation drugs: oseltamivir and zanarnivir and also old generation drugs: amantadine and rimantadine. Since these antivirals are effective only in the case of influenza infection, diagnostic tests should be performed previously. Present methods allow to obtain the result of the test within less than l hour to 8 h. This is of great importance, because the administration of the drug within 36 h from the onset of symptoms is one of the factors condition­ing the effectiveness of antiviral therapy. In the present paper there are described four cases of hospitalized patients in whom the infection with influenza virus was confirmed by immunofluorescence test and RT-PCR, and then the antiviral-antiinfluenza drugs were immediately introduced. This antiviral therapy in a short time resulted in the improvement of patients' condition and allowed to discharge them from the hospital. Antiviral-antiinfluenza drugs together with virological diagnostics are the effective tool in the case of patients not vaccinated against influenza, who were infected with influenza virus and fell ill. Full article
172 KiB  
Article
Hyperuricaemia in Females with Obstructive Sleep Apnoea
by Robert Pływaczewski, Michał Bednarek, Luiza Jonczak, Dorora Górecka and Paweł Śliwiński
Adv. Respir. Med. 2006, 74(2), 159-165; https://doi.org/10.5603/ARM.28045 - 10 Jun 2006
Viewed by 271
Abstract
The aim of our study was to assess serum uric acid (UA) in a large group of females with OSA before treatment (normal UA value is from 2.4 to 5.7 mg/dL). We studied 105 consecutive females (73.3% without es­trogen activity), mean age 58.5 [...] Read more.
The aim of our study was to assess serum uric acid (UA) in a large group of females with OSA before treatment (normal UA value is from 2.4 to 5.7 mg/dL). We studied 105 consecutive females (73.3% without es­trogen activity), mean age 58.5 ± 9.9 years, mean BMI = 33.3 ± 8.2 kg/m2 with OSA (mean AHI = 35.6 ± 21.5, mean overnight SaO2 = 89 ± 6.3%). We divided patients in two groups: 1st with hyperuricaemia-UA > 5.7 mg/dL (53 pts, 50.5%) and 2nd with normouricaemia-UA ≤ 5.7 mg/dL (52 pts, 49.5%). Concentartion of serum uric acid was similar in females with and without estrogen activity. Subjects with hyperuricaemia had significantly higher BMI (p < 0.001), lower mean SaO2 (p < 0.01) and spent more time in desaturation below 90% (p < 0.01). This group had lower FVC, FEV1 i PaO2 (p < 0.001), higher PaCO2 (p < 0.01) and morning glucose (p < 0.001). Females with OSA and hyperuricaemia presented higher prevalence of systemic hypertension (p < 0.001 ), coronary artery disease (p < 0.05), diabetes (not significant) and COPD (p < 0.05). Multiple regression analysis revealed relation between serum uric acid, BMI and arterial hypertension. Conclusions: Hyperuricaemia is frequent in females with OSA. Increased UA levels were related especially to obesity and arterial hypertension. Lower: overnight SaO2, FVC, FEV1, PaO2 and higher glucose concentration and PaCO2 may play role in developing of hyperuricaemia. Full article
126 KiB  
Article
Safety of Venom Immunotherapy in Patients Pretreated with Antihistamines—A Retrospective Study
by Damian Tworek, Małgorzata Bocheńska-Marciniak, Maciej Kupczyk, Izabela Kupryś-Lipińska and Piotr Kuna
Adv. Respir. Med. 2006, 74(2), 153-158; https://doi.org/10.5603/ARM.28044 - 10 Jun 2006
Viewed by 290
Abstract
Imrnunotherapy is the only effective method of treatment of allergy to Hymenoptera venom. Pretreat­ment with antihistamines diminishes the incidence of adverse reactions (AR) such as large local and mild systemic reactions but it is suggested that it may mask a development of serious [...] Read more.
Imrnunotherapy is the only effective method of treatment of allergy to Hymenoptera venom. Pretreat­ment with antihistamines diminishes the incidence of adverse reactions (AR) such as large local and mild systemic reactions but it is suggested that it may mask a development of serious allergic reactions. The aim of the study was a retrospective evaluation of the incidence and nature of AR during venom immuno­therapy in patients receiving pretreatment with antihistamines in the Department of Pneumonology and Allergy of the Medical University of Lodz. Results: 50 patients started “ultra-rush” immunotherapy in our center, 8 were taken in our care after the initiation phase had been conducted elsewhere. During the dose increase phase IO systemic adverse reactions were observed. 50% of them were only subjective and the rest mild objective reactions. During the maintenance phase IO systemic reactions were noted, among them 2 cases of the anaphylactic shock. The incidence of systemic adverse reactions was I per 86 injections. Late as well as unusual reactions appeared twice. Conclusions: Venom immunotherapy combined with pretreatment with antihistamines is safe. A vast majority of systemic adverse reactions is of subjective and mild objective nature and appropriate treatment leads to contain­ment of severe reactions. Full article
111 KiB  
Article
The Epidemiology of Tuberculosis of the Respiratory Tract in TH Homeless in Poznań
by Lidia Karpińska-Jazdon, Jerzy Gałęcki and Anna Ruszczcak
Adv. Respir. Med. 2006, 74(2), 149-152; https://doi.org/10.5603/ARM.28043 - 10 Jun 2006
Viewed by 365
Abstract
The Department of Health and Social Care of the Municipal Council in Poznan initiated a programme of prophylaxis against tuberculosis in the homeless. The study involves those homeless people who are registered in Poznan-based homeless shelters and temporary residential sites. Chest X-ray was [...] Read more.
The Department of Health and Social Care of the Municipal Council in Poznan initiated a programme of prophylaxis against tuberculosis in the homeless. The study involves those homeless people who are registered in Poznan-based homeless shelters and temporary residential sites. Chest X-ray was performed in 403 homeless and 57 persons of staff. Abnormal picture of the chest was found in 83 person, but only in 30 lesions were suspected of tuberculous etiology. 43 persons with abnormal chest X-ray and/or with clinical symptoms were exactly examinated in Chest Clinic (with microbiological examination of sputum or bronchoscopic material). AFB were found in 7 of them, in 1-granulomatosis with necrosis was found in lung specimen and in 2 clinical and radiological diagnosis of TB was estabilished. Full article
161 KiB  
Article
The Frequency of Allergy in Lung Cancer Patients
by Katarzyna Tolak, Andrzej Omernik, Oksana Żdan, Diana Ragus, Joanna Domagała-Kulawik, Piotr Rudziński and Ryszard Chazan
Adv. Respir. Med. 2006, 74(2), 144-148; https://doi.org/10.5603/ARM.28042 - 10 Jun 2006
Viewed by 340
Abstract
Lung cancer is the most common malignancy in the world and frequency of allergic diseases increases especially in high-developed countries. In the literature there have been published articles about association be­tween lung cancer and allergic diseases, which don't give a simple answer if [...] Read more.
Lung cancer is the most common malignancy in the world and frequency of allergic diseases increases especially in high-developed countries. In the literature there have been published articles about association be­tween lung cancer and allergic diseases, which don't give a simple answer if there is any connection between them. The aim of this study was the assessment of frequency of allergy in patients with lung cancer. The study was based on medical records and questionnaire performed among patients hospitalized in Department of Pneumonology and Allergology Medical University of Warsaw and in Department of Thoracic Surgery Institute of Tuberculosis in Warsaw. The study included 113 patients (30 women and 83 men). Coexistence of allergy with primary lung cancer was observed in 7 cases which makes 6.2% (frequency of: asthma 1.8%, allergy to drugs 3.5%, allergy to animal's dander 0.9%). The result of this examination reveals that there is significant lower frequency of allergic diseases in patients with lung cancer in comparison with frequency of allergic diseases in adult population of Poland estimated at 15.8%. Full article
119 KiB  
Editorial
Differences between Guidelines on Management of COPD
by Agnieszka Gawlewicz-Mroczka and Ewa Niżankowska-Mogilnicka
Adv. Respir. Med. 2006, 74(2), 139-143; https://doi.org/10.5603/ARM.28041 - 10 Jun 2006
Viewed by 290
Abstract
Przewlekla obturacyjna choroba pruc (POChP) jest chorobct na która w ostatnich latach zawrócono wieksza uwage [...] Full article
Previous Issue
Next Issue
Back to TopTop